ASTX-660 Freebase from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
ASTX-660 Freebase

Description

ASTX-660 is found to be an IAP as well as XIAP inhitor that could be significant in the studies of lymphoma and solid tumours. It is still under Phase I/II trial